FPR1 Antagonist (BOC-MLF) Inhibits Amniotic Epithelial-mesenchymal Transition
Elevated #FPR1 drives #inflammation and #EpithelialMesenchymalTransition in #FetalMembranes during premature rupture, while the BOC-MLF reduces inflammation and preserves #collagen structure, highlighting a potential preventive strategy for PROM.
Read: doi.org/10.1007/s115...
1
1
0
0